The BIOSECURE Act in the FY 2026 NDAA is a quiet, sweeping shift in federal supply-chain enforcement that reaches beyond “biotech” and into the tools most companies barely think about like software, AI, data platforms, and third-party services used behind the scenes. As Alex Major and Franklin Turner write in The Government Contractor, BIOSECURE Act risk will hide several layers down and surface only when a bid, grant, or transaction is already at risk with IP, compliance, and access to federal markets can all be affected by vendors no one mapped years ago.